Optimizing Care for Patients With Triple-Negative Breast Cancer Through Pharmacist Interventions in Supportive Care and Toxicity Management

Add-on activity

This activity includes patient counseling video vignettes.

Program Description

Pharmacists have important roles in ensuring medication adherence and providing supportive care management to patients with triple-negative breast cancer (TNBC). This module will review strategies for pharmacists to optimize and personalize management of patients with TNBC. Specific toxicities associated with poly (ADP-ribose) polymerase (PARP) inhibitors, immune checkpoint inhibitors, and antibody-drug conjugates will be discussed, with a focus on the pharmacist’s role in monitoring for and mitigating adverse effects of therapy. In addition, counseling points regarding medication administration, potential drug interactions, and barriers to adherence will be covered to assist pharmacists in providing individualized supportive care for patients with TNBC. Counseling videos incorporated throughout this activity will provide pharmacists with key pearls to provide when educating patients with TNBC about treatment expectations, adverse effect management, and provision of supportive care.

Target audience: Health-system, managed care, oncology, and specialty pharmacists

Type of activity: Application
Release date: August 26, 2022
Expiration date: August 26, 2023

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify the role of the pharmacist in the provision of supportive care for patients with triple-negative breast cancer (TNBC)
• Analyze the toxicities specific to novel agents such as poly (ADP-ribose) polymerase (PARP) inhibitors, immune checkpoint inhibitors, and antibody-drug conjugates for the treatment of TNBC
• Develop a plan to effectively mitigate, monitor, or treat toxicities associated with novel drug therapies for the treatment of TNBC

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-22-401-H01-P. The activity is available for CE credit through August 26, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Craig Vargo, PharmD, BCOP

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy Seung, PharmD, BCOP, FHOPA; Amy Morris, PharmD; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms